BIO Professional Development
Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth
Clinical Development 301: Phase II/III
Clinical Development 301: Phase II/III considers the purpose, design, and conduct of Phase II and III clinical trials. Learn the various trial design approaches, endpoint choices, statistical considerations, and special regulatory designations.
![bio-course-directory-image-2 (1).png](/sites/default/files/2021-01/bio-course-directory-image-2%20%281%29.png)
Clinical Development 301: Phase II/III Course Trailer
Takeaways
- Key differences between early stage (Phase I) and late-stage (Phase II/III) clinical trials.
- Regulatory significance of clinical endpoint, primary endpoint, secondary endpoint, surrogate endpoint.
- Fluency in Phase II and Phase III clinical trial nuances.
- Basic statistical analysis completed in late-stage trials.
- Description of specialized and expedited development cycles for rare disease, orphan drugs, and therapies for unmet medical needs.
Download Course Syllabus
Clinical Development 301 Phase I/II Agenda
Course offered by
![Courses offered by BiotechPrimer](/sites/default/files/2024-04/biotech-primer-2024-500px.png)
![](/act-root/bio/assets/images/icon/price_big.png)
Course Price:
$150 USD
![](/act-root/bio/assets/images/icon/bio_price_big.png)
BIO Member Price:
$120 USD
![](/act-root/bio/assets/images/icon/time_big.png)
Course Length:
55 minutes
![](/act-root/bio/assets/images/icon/level_big.png)
Course Level:
Advanced
![](/act-root/bio/assets/images/icon/completion_period_big.png)
Completion Period:
2 weeks
![](/act-root/bio/assets/images/icon/format_big.png)
Course Format:
On-Demand
Certificate Requirements
- View entire course
- Pass the course exam with a 70%
- Complete the course evaluation